[Clinical experiences with urokinase].
D000917:Antibody Formation; D001780:Blood Coagulation Tests; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy; D004789:Enzyme Activation; D005169:Factor VIII; D005341:Fibrinolysin / Q000037:antagonists & inhibitors; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008259:Macroglobulins / Q000378:metabolism; D010958:Plasminogen; D012770:Shock, Cardiogenic / Q000188:drug therapy; D013300:Streptokinase / Q000627:therapeutic use; D013923:Thromboembolism / Q000188:drug therapy*; D014361:Trypsin Inhibitors
D005343:Fibrinolytic Agents; D008259:Macroglobulins; D014361:Trypsin Inhibitors; D005169:Factor VIII; D010958:Plasminogen; D013300:Streptokinase; D005341:Fibrinolysin
Klinische Erfahrungen bei der Anwendung von Urokinase.